Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

Lior mor

355 POSTS

Exclusive articles:

SKN | Cohen & Steers Holds Steady Ahead of Earnings as Income Appeal Meets Market Pressure

Asset Manager Trades Flat as Investors Await Key Catalyst Cohen & Steers, Inc. (NYSE: CNS) remained relatively stable, closing at $66.39, up marginally by 0.17%....

SKN | Global X Space Tech ETF: New Space Economy Investment Vehicle Targets Growing Aerospace Market

Global X is preparing to bring the Global X Space Tech ETF to market with an initial public offering aimed at raising approximately $8...

SKN | Credo Technology Surges Nearly 19% as AI Connectivity Demand Fuels Momentum

Shares of Credo Technology Group Holding Ltd (CRDO) surged +18.73% to $159.52, marking one of the stock’s strongest recent moves as investor enthusiasm builds...

SKN | Elmet Group Targets $100M IPO Amid Rising Demand for Defense and Advanced Materials

A Strategic IPO in a High-Demand Sector The Elmet Group, a U.S.-based manufacturer specializing in high-performance materials and microwave technologies, has officially set terms for...

SKN | TSM Earnings Preview: AI Boom Fuels Record Growth Expectations

Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) heads into its April 16, 2026 earnings release with exceptionally high expectations, driven by surging global demand...

Breaking

SKN | Geothermal Developer Fervo Energy Files for Estimated $250 Million IPO

Fervo Energy, a next-generation geothermal energy developer, has filed...

SKN | Mobia Medical Files for $100M IPO as Neurostimulation Therapy Targets $30B Stroke Market

FDA-Approved Device Positions Company in High-Value Neurorehabilitation Segment Mobia Medical...

SKN | Amatuhi Holdings Raises IPO Range as Investor Demand Lifts Expected Proceeds by 60%

Revised Pricing Signals Stronger Market Interest Ahead of Nasdaq...

SKN | Alamar Biosciences Prices Upsized IPO at $17, the High End of the Range

Alamar Biosciences has priced its upsized initial public offering...
spot_imgspot_img